BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37022163)

  • 41. Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.
    Garcia M; Spatz SJ; Cheng Y; Riblet SM; Volkening JD; Schneiders GH
    J Gen Virol; 2016 Sep; 97(9):2352-2362. PubMed ID: 27283114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attenuated vaccines can recombine to form virulent field viruses.
    Lee SW; Markham PF; Coppo MJ; Legione AR; Markham JF; Noormohammadi AH; Browning GF; Ficorilli N; Hartley CA; Devlin JM
    Science; 2012 Jul; 337(6091):188. PubMed ID: 22798607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
    Devlin JM; Hartley CA; Gilkerson JR; Coppo MJ; Vaz P; Noormohammadi AH; Wells B; Rubite A; Dhand NK; Browning GF
    Vaccine; 2011 Aug; 29(34):5699-704. PubMed ID: 21689710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene.
    Lüschow D; Werner O; Mettenleiter TC; Fuchs W
    Vaccine; 2001 Jul; 19(30):4249-59. PubMed ID: 11457552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Full genomic characterisation of an emerging infectious laryngotracheitis virus class 7b from Australia linked to a vaccine strain revealed its identity.
    Sabir AJ; Olaogun OM; O'Rourke D; Fakhri O; Coppo MJC; Devlin JM; Konsak-Ilievski B; Noormohammadi AH
    Infect Genet Evol; 2020 Mar; 78():104067. PubMed ID: 31678646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycoprotein G (gG) production profile during infectious laryngotracheitis virus (ILTV) infection.
    Bendezu J; Morales Ruiz S; Montesinos R; Choque Guevara R; Rojas-Neyra A; Pauyac-Antezana K; Fernández-Díaz M
    PLoS One; 2019; 14(8):e0219475. PubMed ID: 31433806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus.
    Korsa MG; Browning GF; Coppo MJ; Legione AR; Gilkerson JR; Noormohammadi AH; Vaz PK; Lee SW; Devlin JM; Hartley CA
    PLoS One; 2015; 10(9):e0137719. PubMed ID: 26366738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines.
    Johnson DI; Vagnozzi A; Dorea F; Riblet SM; Mundt A; Zavala G; García M
    Avian Dis; 2010 Dec; 54(4):1251-9. PubMed ID: 21313847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytokine gene transcription in the trachea, Harderian gland, and trigeminal ganglia of chickens inoculated with virulent infectious laryngotracheitis virus (ILTV) strain.
    Vagnozzi AE; Beltrán G; Zavala G; Read L; Sharif S; García M
    Avian Pathol; 2018 Oct; 47(5):497-508. PubMed ID: 29963906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.
    Lee SW; Markham PF; Coppo MJ; Legione AR; Shil NK; Quinteros JA; Noormohammadi AH; Browning GF; Hartley CA; Devlin JM
    Avian Dis; 2014 Mar; 58(1):147-52. PubMed ID: 24758128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis and tissue tropism of natural field recombinants of infectious laryngotracheitis virus.
    Thilakarathne DS; Noormohammadi AH; Browning GF; Quinteros JA; Underwood GJ; Hartley CA; Coppo MJ; Devlin JM; Diaz-Méndez A
    Vet Microbiol; 2020 Apr; 243():108635. PubMed ID: 32273014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latency characteristics in specific pathogen-free chickens 21 and 35 days after intra-tracheal inoculation with vaccine or field strains of infectious laryngotracheitis virus.
    Thilakarathne DS; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Coppo MJC; Devlin JM
    Avian Pathol; 2020 Aug; 49(4):369-379. PubMed ID: 32352307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
    Coppo MJ; Devlin JM; Noormohammadi AH
    Avian Pathol; 2012; 41(1):99-106. PubMed ID: 22845327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis.
    Kirkpatrick NC; Mahmoudian A; Colson CA; Devlin JM; Noormohammadi AH
    Avian Pathol; 2006 Dec; 35(6):449-53. PubMed ID: 17121733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant infectious laryngotracheitis virus expressing Newcastle disease virus F protein protects chickens against infectious laryngotracheitis virus and Newcastle disease virus challenge.
    Shao Y; Sun J; Han Z; Liu S
    Vaccine; 2018 Dec; 36(52):7975-7986. PubMed ID: 30448332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phylogenetic Evidence of a Close Relationship between the Peruvian Strain Vfar-043 and Two U.S. Origin Iltv Field Strains.
    Morales Ruiz S; Bendezu J; Tataje-Lavanda L; Fernández-Díaz M
    Avian Dis; 2018 Dec; 62(4):388-396. PubMed ID: 31119923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
    Vagnozzi A; García M; Riblet SM; Zavala G
    Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of Newcastle Disease Virus (NDV) Recombinants Expressing the Infectious Laryngotracheitis Virus (ILTV) Glycoprotein gB or gD as Dual Vaccines.
    Zhao W; Spatz S; Zsak L; Yu Q
    Methods Mol Biol; 2016; 1404():89-101. PubMed ID: 27076292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Field Application of qPCR Monitoring of Infectious Laryngotracheitis Virus in Settled Chicken House Dust and Its Role in Control of a Major Outbreak.
    Assen AM; Groves PJ; Etherington A; Gerber PF; Sexton M; Williamson S; Walkden-Brown SW
    Avian Dis; 2022 Oct; 66(3):1-9. PubMed ID: 36106910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Whole-Genome Sequences of Infectious laryngotracheitis Virus Isolates from Poultry Flocks in Canada: Evidence of Recombination.
    Perez Contreras A; van der Meer F; Checkley S; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Provost C; Ojkic D; Abdul-Careem MF
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33198373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.